167 related articles for article (PubMed ID: 1919013)
1. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
2. Heat- or stress-inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast.
Konno A; Sato N; Yagihashi A; Torigoe T; Cho JM; Torimoto K; Hara I; Wada Y; Okubo M; Takahashi N
Cancer Res; 1989 Dec; 49(23):6578-82. PubMed ID: 2555046
[TBL] [Abstract][Full Text] [Related]
3. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
4. [Expression of cell surface transformation-associated antigens TAAs on activated oncogene-transfected rat fibroblast and antitumor immunity by hosts].
Sato N; Yagihashi A; Konno A; Torigoe T; Kikuchi K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):653-61. PubMed ID: 2705790
[TBL] [Abstract][Full Text] [Related]
5. [Biochemical characterization of tumor rejection antigen (TRA) and genetic control in anti-TRA immune responses].
Fujiwara H; Suda T; Shimizu J; Muramatsu M; Kimura K; Hamaoka T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):646-52. PubMed ID: 2468311
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
7. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.
Hollingsworth MA; Rebellato LM; Moore JW; Finn OJ; Metzgar RS
Cancer Res; 1986 May; 46(5):2482-7. PubMed ID: 3697988
[TBL] [Abstract][Full Text] [Related]
8. Morphological transformation, tumorigenicity and src-specific cytotoxic T-lymphocyte-mediated tumor immunity induced by murine 3T3 cells expressing src oncogenes encoding novel non-myristylated N-terminal domains.
Gelman IH; Khan S; Hanafusa H
Oncogene; 1993 Nov; 8(11):2995-3004. PubMed ID: 7692370
[TBL] [Abstract][Full Text] [Related]
9. The expression of tumor rejection antigen on rat fetus fibroblasts transformed by the ras oncogene.
Okubo M; Yagihashi A; Torigoe T; Konno A; Sato N; Kikuchi K
Jpn J Cancer Res; 1988 Jul; 79(7):850-6. PubMed ID: 3139598
[TBL] [Abstract][Full Text] [Related]
10. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
Tough DF; Feng X; Chow DA
Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
[TBL] [Abstract][Full Text] [Related]
11. Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells.
Tatsuka M; Ota T; Yamagishi N; Kashihara Y; Wada M; Matsuda N; Mitsui H; Seiki M; Odashima S
Mol Carcinog; 1996 Apr; 15(4):300-8. PubMed ID: 8634088
[TBL] [Abstract][Full Text] [Related]
12. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
13. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
Douvdevani A; Huleihel M; Segal S; Apte RN
Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
15. Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfection with immortalizing and transforming genes.
Van Roy FM; Messiaen L; Liebaut G; Gao J; Dragonetti CH; Fiers WC; Mareel MM
Cancer Res; 1986 Sep; 46(9):4787-95. PubMed ID: 3015398
[TBL] [Abstract][Full Text] [Related]
16. Transformation of rat bladder epithelial cells by introduction of a single oncogene.
Mann AM; Stevenson M; Masui T; Borgeson CD; Cohen SM
Oncogene Res; 1991; 6(1):65-72. PubMed ID: 1847743
[TBL] [Abstract][Full Text] [Related]
17. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells.
Goyette M; Faris R; Braun L; Hixson D; Fausto N
Cancer Res; 1990 Aug; 50(15):4809-17. PubMed ID: 2196118
[TBL] [Abstract][Full Text] [Related]
19. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Roth JA; Scuderi P; Westin E; Gallo RC
Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated oncogene transfer into neural transplants.
Wiestler OD; Brüstle O; Eibl RH; Radner H; Aguzzi A; Kleihues P
Brain Pathol; 1992 Jan; 2(1):47-59. PubMed ID: 1341947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
